Omar Dzaye1,2, Philipp Berning3, Zeina A Dardari1, Martin Bødtker Mortensen1,4, Catherine Handy Marshall1, Khurram Nasir5, Matthew J Budoff6, Roger S Blumenthal1, Seamus P Whelton1, Michael J Blaha1. 1. Johns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Blalock 524D1, 600 N Wolfe St, Baltimore, MD 21287, USA. 2. Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 3. Department of Hematology and Oncology, University Hospital Muenster, Muenster, Germany. 4. Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark. 5. Division of Cardiovascular Prevention and Wellness, Houston Methodist DeBakey Heart & Vascular Center, Houston, TX, USA. 6. Department of Medicine, Lundquist Institute, Harbor-UCLA Medical Center, Torrance, CA, USA.
Abstract
AIMS: This study explored the association of coronary artery calcium (CAC) with incident cancer subtypes in the Multi-Ethnic Study of Atherosclerosis (MESA). CAC is an established predictor of cardiovascular disease (CVD), with emerging data also supporting independent predictive value for cancer. The association of CAC with risk for individual cancer subtypes is unknown. METHODS AND RESULTS: We included 6271 MESA participants, aged 45-84 and without known CVD or self-reported history of cancer. There were 777 incident cancer cases during mean follow-up of 12.9 ± 3.1 years. Lung and colorectal cancer (186 cases) were grouped based on their strong overlap with CVD risk profile; prostate (men) and ovarian, uterine, and breast cancer (women) were considered as sex-specific cancers (in total 250 cases). Incidence rates and Fine and Gray competing risks models were used to assess relative risk of cancer-specific outcomes stratified by CAC groups or Log(CAC+1). The mean age was 61.7 ± 10.2 years, 52.7% were women, and 36.5% were White. Overall, all-cause cancer incidence increased with CAC scores, with rates per 1000 person-years of 13.1 [95% confidence interval (CI): 11.7-14.7] for CAC = 0 and 35.8 (95% CI: 30.2-42.4) for CAC ≥400. Compared with CAC = 0, hazards for those with CAC ≥400 were increased for lung and colorectal cancer in men [subdistribution hazard ratio (SHR): 2.2 (95% CI: 1.1-4.7)] and women [SHR: 2.2 (95% CI: 1.0-4.6)], but not significantly for sex-specific cancers across sexes. CONCLUSION: CAC scores were associated with cancer risk in both sexes; however, this was stronger for lung and colorectal when compared with sex-specific cancers. Our data support potential synergistic use of CAC scores in the identification of both CVD and lung and colorectal cancer risk. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: This study explored the association of coronary artery calcium (CAC) with incident cancer subtypes in the Multi-Ethnic Study of Atherosclerosis (MESA). CAC is an established predictor of cardiovascular disease (CVD), with emerging data also supporting independent predictive value for cancer. The association of CAC with risk for individual cancer subtypes is unknown. METHODS AND RESULTS: We included 6271 MESA participants, aged 45-84 and without known CVD or self-reported history of cancer. There were 777 incident cancer cases during mean follow-up of 12.9 ± 3.1 years. Lung and colorectal cancer (186 cases) were grouped based on their strong overlap with CVD risk profile; prostate (men) and ovarian, uterine, and breast cancer (women) were considered as sex-specific cancers (in total 250 cases). Incidence rates and Fine and Gray competing risks models were used to assess relative risk of cancer-specific outcomes stratified by CAC groups or Log(CAC+1). The mean age was 61.7 ± 10.2 years, 52.7% were women, and 36.5% were White. Overall, all-cause cancer incidence increased with CAC scores, with rates per 1000 person-years of 13.1 [95% confidence interval (CI): 11.7-14.7] for CAC = 0 and 35.8 (95% CI: 30.2-42.4) for CAC ≥400. Compared with CAC = 0, hazards for those with CAC ≥400 were increased for lung and colorectal cancer in men [subdistribution hazard ratio (SHR): 2.2 (95% CI: 1.1-4.7)] and women [SHR: 2.2 (95% CI: 1.0-4.6)], but not significantly for sex-specific cancers across sexes. CONCLUSION: CAC scores were associated with cancer risk in both sexes; however, this was stronger for lung and colorectal when compared with sex-specific cancers. Our data support potential synergistic use of CAC scores in the identification of both CVD and lung and colorectal cancer risk. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Mahmoud Al Rifai; Andrew P DeFilippis; John W McEvoy; Michael E Hall; Ana Navas Acien; Miranda R Jones; Rachel Keith; Hoda S Magid; Carlos J Rodriguez; Graham R Barr; Emelia J Benjamin; Rose Marie Robertson; Aruni Bhatnagar; Michael J Blaha Journal: Atherosclerosis Date: 2017-01-19 Impact factor: 5.162
Authors: Allison W Peng; Mohammadhassan Mirbolouk; Olusola A Orimoloye; Albert D Osei; Zeina Dardari; Omar Dzaye; Matthew J Budoff; Leslee Shaw; Michael D Miedema; John Rumberger; Daniel S Berman; Alan Rozanski; Mouaz H Al-Mallah; Khurram Nasir; Michael J Blaha Journal: JACC Cardiovasc Imaging Date: 2019-03-15
Authors: Alain G Bertoni; Melicia C Whitt-Glover; Hyoju Chung; Katherine Y Le; R Graham Barr; Mahadevappa Mahesh; Nancy S Jenny; Gregory L Burke; David R Jacobs Journal: Am J Epidemiol Date: 2008-12-15 Impact factor: 4.897
Authors: Catherine E Handy; Chintan S Desai; Zeina A Dardari; Mouaz H Al-Mallah; Michael D Miedema; Pamela Ouyang; Matthew J Budoff; Roger S Blumenthal; Khurram Nasir; Michael J Blaha Journal: JACC Cardiovasc Imaging Date: 2016-03-09
Authors: Michael J Blaha; Miguel Cainzos-Achirica; Zeina Dardari; Ron Blankstein; Leslee J Shaw; Alan Rozanski; John A Rumberger; Omar Dzaye; Erin D Michos; Daniel S Berman; Matthew J Budoff; Michael D Miedema; Roger S Blumenthal; Khurram Nasir Journal: Atherosclerosis Date: 2019-11-16 Impact factor: 5.162
Authors: Seamus P Whelton; Mahmoud Al Rifai; Zeina Dardari; Leslee J Shaw; Mouaz H Al-Mallah; Kunihiro Matsushita; John A Rumberger; Daniel S Berman; Matthew J Budoff; Michael D Miedema; Khurram Nasir; Michael J Blaha Journal: Eur Heart J Cardiovasc Imaging Date: 2019-04-01 Impact factor: 6.875
Authors: Tamar S Polonsky; Hongyan Ning; Martha L Daviglus; Kiang Liu; Gregory L Burke; Mary Cushman; John Eng; Aaron R Folsom; Pamela L Lutsey; Jennifer A Nettleton; Wendy S Post; Ralph L Sacco; Moyses Szklo; Donald M Lloyd-Jones Journal: J Am Heart Assoc Date: 2017-03-20 Impact factor: 5.501
Authors: Abdulhamied Alfaddagh; Seth S Martin; Thorsten M Leucker; Erin D Michos; Michael J Blaha; Charles J Lowenstein; Steven R Jones; Peter P Toth Journal: Am J Prev Cardiol Date: 2020-11-21